Is 5-MAPB Legal in Arkansas? (2026)

Instrument

Controlled substance analog

Source

https://advance.lexis.com/container?config=Arkansas+Code

Retrieved

2026-07-20

Fingerprint

8b08e9b5aa606d97

(a)(1) "Controlled substance analog" means a substance: (A) The chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or Schedule II or that has a stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance included in Schedule I or Schedule II; or (B) With respect to a particular individual, that the individual represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance included in Schedule I or Schedule II. (2) "Controlled substance analog" does not include: (A) A controlled substance; (B) A substance for which there is an approved new drug application; (C) A substance with respect to which an exemption is in effect for investigational use by a particular person under Sec. 505 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. Sec. 355, to the extent conduct with respect to the substance is pursuant to the exemption; or (D) Any substance to the extent not intended for human consumption before an exemption takes effect with respect to the substance. (b) A controlled substance analog, to the extent intended for human consumption, is treated for the purposes of this chapter as a substance included in Schedule I. (c) Within ten (10) days after the initiation of prosecution with respect to a controlled substance analog by indictment or information, the prosecuting attorney shall notify the Secretary of the Department of Health of information relevant to emergency scheduling as provided for in Sec. 5-64-201(a). (d) After final determination that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may continue or take place.

Instrument

Arkansas List of Controlled Substances (Dept. of Health rule), Article II Schedule I, (d) hallucinogenic substances

Source

https://codeofarrules.arkansas.gov/Rules/PartDocument?partID=705

Retrieved

2026-10-08

Fingerprint

0e4bb5ed5f750abf

ARTICLE II SCHEDULE I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Opiates: (Narcotic Drugs) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers): (1) Acetylmethadol 9601* (2) Allylprodine 9602* (3) Alphacetylmethadol (except Levo-alphacetylmethadol (LAAM) 9603* (4) Alphameprodine 9604* (5) Alphamethadol 9605* (6) Benzethidine 9606* (7) Betacetylmethadol 9607* (8) Betameprodine 9608* (9) Betamethadol 9609* (10) Betaprodine 9611* (11) Dextromoramide 9613* (12) Diampromide 9615* (13) Diethylthiambutene 9616* (14) Difenoxin 9168* (15) Dimenoxadol 9617* (16) Dimepheptanol 9618* (17) Dimethylthiambutene 9619* (18) Dioxaphetyl butyrate 9621* (19) Dipipanone 9622* (20) Ethylmethylthiambutene 9623* (21) Etoxeridine 9625* (22) Furethidine 9626* (23) Hydroxypethidine 9627* Page 2 (24) Ketobemidone 9628* (25) Levomoramide 9629* (26) Levophenacylmorphan 9631* (27) Morpheridine 9632* (28) MPPP [other name(s): (1-methyl-4-phenyl-4-propionoxypiperidine)] 9661-(10-1985) (29) Noracymethadol 9633* (30) Norlevorphanol 9634* (31) Normethadone 9635* (32) Norpipanone 9636* (33) PEPAP [other name(s): 1-(2-phenylethyl)-4-phenyl-4 acetyloxypiper-idine] - 9663-(10-1985) (34) Phenadoxone 9637* (35) Phenampromide 9638* (36) Phenomorphan 9647* (37) Phenoperidine 9641* (38) Piritramide 9642* (39) Proheptazine 9643* (40) Properidine 9644* (41) Propiram 9649* (42) Racemoramide 9645* (43) Tilidine 9750-(9-1981) (44) Trimeperidine 9646* (45) Acetyl norfentanyl [other name(s): N-phenyl-N-4-piperidinyl-acetamide] (4-2017) (46) AH-7921 [other name(s): 3,4-dichloro-N-[(1- dimethylamino)cyclohexylmethyl]benzamide] 9551-(4-2017) (47) W-18 [other name(s): 1-(4-nitrophenylethyl)piperidylidene-2-(4- chlorophenyl)sulfonamide] (4-2017) (48) W-15 [other name(s): 1-phenylethylpiperidylidene-2-(4- chlorophenyl)Sulfonamide] (4-2017) (49) MT-45 [other name(s): 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine] 9560-(4-2017) (50) U-47700 [other name(s): trans-3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)- N-methylbenzamide] 9547-(4-2017) (51) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. Fentanyl-related substance means any substance not otherwise listed, and for which no exemption or approval is in effect under section Page 3 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that is structurally related to fentanyl by one or more of the following modifications: (4-2021) (i) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle; (ii) Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups; (iii)Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups; (iv) Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or (v) Replacement of the N-propionyl group by another acyl group. (vi) Fentanyl-related substances shall include, but are not limited to: (A) Acetyl-alpha-methylfentanyl [other name(s): (N-[1-[1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide)] 9815-(2-1986) (B) Alpha-methylfentanyl [other name(s): (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propronanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido)piperidine)] 9814-(6-1982) (C) Alpha-methylthiofentanyl [other name(s): N-[1-methyl-2-(2-thienyl)ethyl- 4-piperidinyl]-N-phenylpropanamide] 9832-(2-1986) (D) Beta-hydroxyfentanyl [other name(s): (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide)] 9830-(2-1986) (E) Beta-hydroxy-3-methylfentanyl [other name(s): N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropamamide] 9831-(2-1986) (F) 3-Methylfentanyl [other name(s): (N-[3-Methyl-1-(2-phenylethyl)-4- piperidyl]-N-Phenylpropanamide)] 9813-(10-1985) (G) 3-methylthiofentanyl [other name(s): N-[(3-methyl-1-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide] 9833-(2-1986) (H) Para-fluorofentanyl [other name(s): (N-[4-fluorophenyl)-N-[1-(2- phenenthyl)-4-piperindinyl]propananmide] 9812-(11-1986) (I) Thiofentanyl [other name(s): (N-phenyl-N-[1-(2-thienyl)ethyl-4- piperidinyl]-propanamide] 9835-(2-1986) (J) Acetyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide] 9821-(4-2017) (K) Butyryl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)-N- phenylbutyramide] 9822-(4-2017) (L) Beta-hydroxythiofentanyl [other name(s): N-{1-[2-hydroxy-2-(thiophen-2- yl)ethyl]piperidin-4-yl}-N-phenylpropionamide] 9836-(4-2017) Page 4 (M) Acetyl fentanyl 4-methylphenethyl analog [other name(s): N-{1-[2- (4-methylphenyl)ethyl]-4-piperidinyl}-N-phenyl-acetamide] (4-2017) (N) Valeryl fentanyl [other name(s): N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl]-pentanamide] 9840-(4-2017) (O) Furanyl fentanyl [other name(s): N-(1-(2-phenylethyl)-4-piperidinyl)-N- phenylfuran-2-carboxamide] 9834-(4-2017) (P) Isobutyryl fentanyl [other name(s): 2-methyl-N-phenyl-N-[1-(2- phenylethyl)-4-piperidinyl]-propanamide] 9827-(4-2017) (Q) Ocfentanil [other name(s): N-(2-fluorophenyl)-2-methoxy-N-[1-(2- phenylethyl)piperidin-4-yl]acetamide] 9838-(4-2017) (R) 4-methoxy butyryl fentanyl [other name(s): N-(4-methoxyphenyl)-N-(1- phenethylpiperidin-4-yl)butyramide] (4-2017) (S) Para-fluorobutyryl fentanyl [other name(s): N-(4-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidinyl]-butanamide] 9823-(4-2017) (T) Acryl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)-N- phenylacrylamide] 9811-(6-2020) (U) 4-Fluoroisobutyryl fentanyl [other name(s): N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide] 9824-(6-2020) (V) Tetrahydrofuranyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran-2-carboxamide] 9843-(6-2020) (W) Cyclopropyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)- N-phenylcyclopropanecarboxamide] 9845-(4-2021) (X) Methoxyacetyl fentanyl [other name(s): 2-methoxy-N-(1- phenethylpiperidin-4-yl)-N-phenylacetamide] 9825-(4-2021) (Y) Ortho-fluorofentanyl [other name(s): N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamide] 9816-(4-2021) (Z) Crotonyl fentanyl [other name(s): (E)-N-(1-phenethylpiperidin-4-yl)-N- phenylbut-2-enamide] 9844-(5-2022) (AA) Cyclopentyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)- N-phenylcyclopentanecarboxamide] 9847-(5-2022) (BB) Para-chloroisobutyryl fentanyl [other name(s): N-(4-chlorophenyl)-N- (1-phenethylpiperidin-4-yl)isobutyramide] 9826-(5-2022) (CC) Para-methoxybutyryl fentanyl [other name(s): N-(4-methoxyphenyl)- N-(1-phenethylpiperidin-4-yl)butyramide] 9837-(5-2022) (DD) Beta-methyl fentanyl [other name(s): N-phenyl-N-(1-(2- phenylpropyl) piperidin-4-yl)propionamide] 9856-(5-2022) (EE) Beta'-phenyl fentanyl [other name: N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide] 9842-(5-2022) Page 5 (FF) 2'-Fluoro ortho-fluorofentanyl [other name(s): N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide] 9855-(5-2022) (GG) 4'-Methyl acetyl fentanyl [other name(s): N-(1-(4-methylphenethyl) piperidin-4-yl)-N-phenylacetamide] 9819-(5-2022) (HH) Ortho-fluorobutyryl fentanyl [other name(s): N-(2-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)butyramide] 9846-(5-2022) (II) Ortho-methyl acetylfentanyl [other name(s): N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide] 9848-(5-2022) (JJ) Ortho-methyl methoxyacetyl fentanyl [other name(s): 2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide] 9820-(5-2022) (KK) Para-methylfentanyl [other name(s): N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide] 9817-(5-2022) (LL) Phenyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)-N- phenylbenzamide] 9841-(5-2022) (MM) Thiofuranyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)- N-phenylthiophene-2-carboxamide] 9839-(5-2022) (NN) Fentanyl carbamate [other name(s): ethyl(1-phenethylpiperidin-4- yl)(phenyl)carbamate] 9851-(5-2022) (OO) Ortho-fluoroacryl fentanyl [other name(s): N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide] 9852-(5-2022) (PP) Ortho-fluoroisobutyryl fentanyl [other name(s): N-(2-fluorophenyl)- N-(1-phenethylpiperidin-4-yl)isobutyramide] 9853-(5-2022) (QQ) Para-fluoro furanyl fentanyl [other name(s): N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide] 9854-(5-2022) (RR) Meta-fluorofentanyl [other name(s): N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamide] 9857-(6-2025) (SS) Meta-fluoroisobutyryl fentanyl [other name(s): N-(3-fluorophenyl)- N-(1-phenethylpiperidin-4-yl)isobutyramide 9858-(6-2025) (TT) Para-methoxyfuranyl fentanyl [other name(s): N-(4-methoxyphenyl)- N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide] 9859-(6-2025) (UU) Para-methylcyclopropyl fentanyl [other name(s): N-(4- methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide] - 9865-(6-2025) (VV) 3-furanyl fentanyl [other name(s): N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-3-carboxamide] 9860-(6-2025) (WW) 2′,5′-dimethoxyfentanyl [other name(s): N-(1-(2,5- dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide] 9861-(6-2025) (XX) Isovaleryl fentanyl [other name(s): 3-methyl-N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide] 9862-(6-2025) Page 6 (YY) Ortho-fluorofuranyl fentanyl [other name(s): N-(2-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide] 9863-(6-2025) (ZZ) Alpha′-methyl butyryl fentanyl [other name(s): 2-methyl-N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide] 9864-(6-2025) (52) Zipeprol 9873-(11-2023) (53) Brorphine 9098-(4-2024) (54) Benzimidazole-opioid substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. Benzimidazole-opioid substances includes any substance, not otherwise listed or excepted, and for which no exemption or approval is in effect under Section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that structurally has benzimidazole ring with an ethylamine at its 1-position and benzyl group at its 2-position: (4-2024) (i) With or without substitution on the benzimidazole; (ii) With or without substitution at the ethylamine; (iii)With or without inclusion of the ethylamine in a cyclic structure; (iv) With or without substitution on the benzyl ring; or (v) With or without replacement of the benzyl ring with an aromatic ring. (vi) Benzimidazole-opioid substances shall include but are not limited to: (A) 4’-Hydroxy Nitazene; (4-2024) (B) 5-Aminoisotonitazene; (4-2024) (C) Butonitazene; 9751-(4-2024) (D) Clonitazene; 9612 * (E) Etodesnitazene, [other name(s): Etazene]; 9765-(4-2024) (F) Etonitazene ; 9624* (G) Flunitazene; 9756-(4-2024) (H) Isotonitazene; 9614-(11-2023) (I) Isotodesnitazene; (4-2024) (J) Metodesnitazene; 9764-(4-2024) (K) Metonitazene; 9757-(4-2024) (L) N-Desethyl Etonitazene; (4-2024) (M) N-Desethyl Isotonitazene ; (4-2024) (N) N-Piperidinyl Etonitazene [other name(s): Etonitazepipne]; (4-2024) (O) N-Pyrrolidino Etonitazene [other name(s): Etonitazepyne]; 9758-(4-2024) (P) N-Pyrrolidino Protonitazene; and (4-2024) (Q) Protonitazene 9759-(4-2024) Page 7 (55) 2-Methyl AP–237 [other name(s): 1-(2-methyl-4-(3-phenylprop-2-en-1- yl)piperazin-1-yl)butan-1-one] 9664-(6-2025) (c) Opium derivatives: (Narcotic Drugs) Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Acetorphine 9319* (2) Acetyldihydrocodeine 9051* (3) Benzylmorphine 9052* (4) Codeine methylbromide 9070* (5) Codeine-N-Oxide 9053* (6) Cyprenorphine 9054* (7) Desomorphine 9055* (8) Dihydromorphine 9145* (9) Drotebanol 9335* (10) Etorphine (except hydrochloride salt) 9056* (11) Heroin 9200* (12) Hydromorphinol 9301* (13) Methyldesorphine 9302* (14) Methyldihydromorphine 9304* (15) Morphine methylbromide 9305* (16) Morphine methylsulfonate 9306* (17) Morphine-N-Oxide 9307* (18) Myrophine 9308* (19) Nicocodeine 9309* (20) Nicomorphine 9312* (21) Normorphine 9313* (22) Pholcodine 9314* (23) Thebacon 9315* (24) Mitragynine (11-2015) (25) 7-Hydroxymitragynine---- (11-2015) (d) Hallucinogenic substances: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following Page 8 hallucinogenic substance, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers): (1) alpha-ethyltryptamine 7249-(12-1993) Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3- ethanamine; 3-(2-aminobutyl)indole; alpha-ET; and AET. (2) 4-bromo-2,5-dimethoxy-amphetamine 7391* Some trade or other names: 4-bromo-2,5-dimethoxy-alpha- methylphenethylamine; 4-bromo-2,5-DMA. (3) 4-bromo-2,5-dimethoxyphenethylamine 7392-(8-1995) Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1 aminoethane; alpha-desmethyl DOB; 2C-B, Nexus. (4) 2,5-dimethoxyamphetamine 7396* Some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5- DMA. (5) 2,5-dimethoxy-4-ethylamphetamine 7399-(3-1988) Some trade or other names: DOET. (6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine 7348-(1-2005) Some trade or other names: 2C-T-7. (7) 4-methoxyamphetamine 7411* Some trade or other names: 4-methoxy-alpha- methylphenethylamine; paramethoxyamphetamine; PMA. (8) 5-methoxy-3,4-methylenedioxy-amphetamine 7401* (9) 4-methyl-2,5-dimethoxyamphetamine 7395* Some trade and other names: 4-methyl-2,5-dimethoxy- alphamethylphenethylamine; "DOM"; and "STP". (10) 3,4-methylenedioxy amphetamine 7400* (11) 3,4-methylenedioxymethamphetamine 7405-(10-1985) Some trade or other names: MDMA) (12) 3,4-methylenedioxy-N-ethylamphetamine 7404-(6-1990) Some trade or other names: N- ethy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA; MDE; MDEA. (13) N-hydroxy-3,4-methylenedioxyamphetamine 7402-(6-1990) Some trade or other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy) phenethylamine; N-hydroxy MDA Page 9 (14) 3,4,5-trimethoxy amphetamine 7390* (15) 5-methoxy-n,n-dimethyltryptamine 5-MeO-DMT 7431*(1-2011) (16) alpha-methyltryptamine 7432-(7-2005) Some trade or other names: AMT (17) Bufotenine 7433* Some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3- (2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N- dimethyltryptamine; mappine. (18) Diethyltryptamine 7434* Some trade or other names: N,N-Diethyltryptamine;DET. (19) Dimethyltryptamine 7435* Some trade or other names: DMT (20) 5-methoxy-N,N-diisopropyltryptamine 7439-(7-2005) Some trade or other names: 5-MeO-DIPT. (21) Ibogaine 7260* Some trade and other names: 7-Ethyl-6,6 beta; 7,8,9,10,12,13-octahydro-2- methoxy-6,9-methano-5H-pyrido [1',2': 1,2] azepino [5,4-b] indole; Tabernanthe iboga. (22) Lysergic acid diethylamide 7315* (23) Mescaline 7381* (24) Parahexyl 7374-(7-1983) Some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9- trimethyl-6H-dibenzo [b,d] pyran; Synhexyl. (25) Peyote 7415* Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts. (Interprets 21 USC 812 (c), Schedule I (c) (12)). (26) N-ethyl-3-piperidyl benzilate 7482* (27) N-methyl-3-piperidyl benzilate 7484* (28) Psilocybin 7437* (29) Psilocyn 7438* (30) Ethylamine Analog of phencyclidine 7455* Page 10 Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE. (31) Pyrrolidine Analog of phencyclidine 7458* Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP (32) Thiophene Analog of phencyclidine 7470* Some trade or other names: 1-[1-(2-thienyl) cyclohexyl] Piperidine; 2-Thienyl analog of phencyclidine; TPCP; TCP. (33) 1-[1-(2-Thienyl)cylcohexyl]pyrrolidine 7473-(9-1989) Some other trade or other names: TCPy. (34) N,N-Diallyl-5-Methoxytryptamine; (6-2012) Some trade or other names: 5-MeO DALT; 5-Methoxy-DALT (35) 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine; 25C-NBOMe (5-2013) (36) 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; 25I-NBOMe (8-2013) (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine; 2C-E 7509-(11-2013) (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine; 2C-D 7508-(11-2013) (39) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine; 2C-C 7519-(11-2013) (40) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine; 2C-I 7518-(11-2013) (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine; 2C-T-2 7385-(11-2013) (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine; 2C-T-4 7532-(11-2013) (43) 2-(2,5-Dimethoxyphenyl)ethanamine; 2C-H 7517-(11-2013) (44) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine; 2C-N 7521-(11-2013) (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine; 2C-P 7524-(11-2013) (46) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 25B- NBOMe (9-2018) (47) 2-[[[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25B- NBOH (11-2018) (48) 2-[[[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25I-NBOH (11-2018) (49) 2-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; 25E-NBOMe (7-2019) (50) 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; 25H- NBOMe (7-2019) (51) 2-[[[2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino]methyl]- phenol; 25C- NBOH (7-2019) Page 11 (52) 2-[[[2-(2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25H-NBOH (7-2019) (53) 1-(4-methoxyphenyl)-N-methylpropan-2-amine 1245-(5-2022) Some trade or other names: Para-methoxymethamphetamine; PMMA (54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286-(11-2023) Some trade or other names: Methoxetamine; MXE (e) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) gamma-hydroxybutyric acid [other name(s): GHB; gamma-hydroxybutyrate; 4- hydroxybutyrate; 4-hydroxydutanoic acid; sodium oxybate; sodium oxybutyrate], and its known precursors and analogs. Precursors include but are not limited to: gamma-butyrolactone 2010-(2-2001) (2) Mecloqualone 2572* (3) Methaqualone 2565* (4) Benzodiazepine substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. Benzodiazepine substances includes any substance, not otherwise listed or excepted, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that structurally has a fused 1,4-diazepine and benzene ring structure with a phenyl connected to the diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or benzene ring, any substitution(s) on the phenyl ring, or any combination thereof. Benzodiazepine substances shall include but are not limited to: (4-2024) (i) Bromazolam; (4-2024) (ii) Clonazolam; (4-2021) (iii)Diclazepam; (iv) Flualprazolam; (4-2021) (v) Flubromazepam; (4-2021) (vi) Flubromazolam; (4-2021) (vii) Phenazepam; (6-2012) (viii) Phenazolam [other name(s): Clobromazolam] (4-2024). (5) Thienodiazepine substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. Thienodiazepine substances includes any substance, not otherwise listed or excepted, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that structurally has a fused 1,4-diazepine and thiophene ring structure with a Page 12 phenyl connected to the 1,4-diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or thiophene ring, any substitution(s) on the phenyl ring, or any combination thereof. Thienodiazepine substances shall include but are not limited to: (4-2024) (i) Etizolam (12-2014) (f) Stimulants: (1) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (i) Cathinone 1235-(3-1988) (ii) (+) CIS-4-Methylaminorex [(+)CIS-4,5-dihydro-4- methyl-5-phenyl-2- oxazolamine] 1590-(6-1990) (iii)Fenethylline 1503-(9-1981) (iv) N-Benzylpiperazine [other name(s): BZP, 1-Benzylpiperazine] 7493-(1-2005) (v) N-ethylamphetamine 1475-(6-1982) (vi) N-[1-(1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers 9818-(2-1986) (vii) N-[1-(2-thienyl)methyl-4-piperidyl)-N-phenylpropan-mide (thenylfentanyl), its optical isomers, salts and salts of isomers 9834-(2-1986) (viii) N,N-Dimethylamphetamine [other name(s): N,N,Alpha- trimethylbenzeneethanamine; N,N,Alpha-trimethylphenethylamine], its salts, optical isomers, and salts of optical isomers 1480-(2-1989) (ix) Methcathinone [other name(s):2-Methylamine-Proprophenone, alpha (methylamino)- Proprophenone, 2 (methylamino)-1-phenylpropan-1-one, alpha-N-Methylaminopropiophenone, monomethylpropion, ephedrone, N- methylcathinone, methycathinone, AL-464, AL-422, AL-463 and UR-1431], its salts, optical isomers and salts of optical isomers 1237-(12-1993) (x) Aminorex [other name(s): aminoraphen, 2-amino-5 phenyl-2-oxazoline, or 4,5 dihyrdo-5-phenyl-2-oxazolamine], its salts, optical isomers, and salts of optical isomers 1585-(12-1993) (xi) 4,4′-Dimethylaminorex [other name(s): 4,4′-DMAR, 4,5-dihydro-4-methyl-5- (4-methylphenyl)-2-oxazolamine, or 4-methyl-5-(4-methylphenyl)-4,5- dihydro-1,3-oxazol-2-amine] 1595-(5-2022) (xii) Amineptine 1219-(11-2023) (xiii) Mesocarb 1227-(11-2023) (xiv) Methyl-N-ethylcathinone (MEC) (6-2014) Page 13 (xv) Methiopropamine. [other name(s): N-methyl-1-(thiophen-2-yl)propan-2- amine] 1478-(4-2024) (xvi) Ethylphenidate [other name(s): ethyl 2-phenyl-2-(piperidin-2-yl)acetate] 1727 (2) Any material, compound, mixture, or preparation, whether produced directly or indirectly from a substance of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis, that contains any quantity of the following substances, or that contains any of the following substances' analogs, salts, isomers, and salts of isomers when the existence of the analogs, salts, isomers, and salts of isomers is possible within the specific chemical designation, with the following chemical structure is included in Schedule I: (i) 4-Methylmethcathinone (Mephedrone) 1248-(3-2011) (ii) Methylenedioxypyrovalerone (MDPV) (3-2011) (iii)3,4-Methylenedioxy-N-methylcathinone (Methylone) 7540-(3-2011) (iv) 4-Methoxymethcathinone (3-2011) (v) 3-Fluoromethcathinone (3-2011) (vi) 4-Fluoromethcathinone (3-2011) (vii) 1-(1,3-benzodioxol-5-yl)-2-methylamino)butan-1-one-(Butylone) 7541-(11-2014) (viii) Alpha-Pyrrolidinopentiophenone (Alpha-PVP) 7545-(11-2015) (ix) 4-methyl-N-ethylcathinone (4-MEC) 1249-(9-2018) (x) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) 7498-(9-2018) (xi) 2-(methylamino)-1-phenylpentan-1-one (Pentedrone) 1246-(9-2018) (xii) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone; bk- MBDP) 7542-(9-2018) (xiii) 4-fluoro-N-methylcathinone (4-FMC, Flephedrone) 1238-(9-2018) (xiv) 3-fluoro-N-methylcathinone (3-FMC) 1233-(9-2018) (xv) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (Naphyrone) 1258-(9-2018) (xvi) Alpha-pyrrolidinobutiophenone ([Alpha]-PBP) 7546-(9-2018) (xvii) 3-methylmethcathinone (3–MMC) 1259-(6-2025) (xviii) A compound, unless listed in another schedule or a legend drug, that is structurally derived from 2-Amino-phenyl-1-propanone by modification or by substitution: (3-2012) (A) In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one (1) or more other univalent substituents; (B) At the 3-position with an alkyl substituent; or Page 14 (C) At the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure. (xix) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one (N-Ethylpentylone) -- 7543-(7-2019) (xx) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (Ethylone) 7547-(4-2021) (xxi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-butanone (Eutylone) 7549-(4-2021) (xxii) 2-(ethylamino)-1-phenylhexan-1-one [other name(s): (N-Ethylhexedrone ; Alpha-Ethylaminohexanophenone)] 7246-(11-2023) (xxiii) 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one [other name(s): (Alpha- Pyrrolidinohexanophenone ; Alpha-PHP)] 7544-(11-2023) (xxiv) 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one [other name(s): (4- Methyl-alpha-ethylaminopentiophenone ; 4-MEAP)] 7245-(11-2023) (xxv) 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one [other name(s): (4′- Methyl-alpha-pyrrolidinohexiophenone ; MPHP)] 7446-(11-2023) (xxvi) 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one [other name(s): (Alpha- Pyrrolidinoheptaphenone ; PV8)] 7548-(11-2023) (xxvii) 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one [other name(s): (4′- Chloro-alpha-pyrrolidinovalerophenone ; 4-chloro-alpha-PVP)] 7443-(11-2023) (xxviii) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one [other name(s): alpha- PiHP, Alpha-Pyrrolidinoisohexanophenone] 7551-(6-2025) (xxix) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one [other name(s): dipentylone, N,N-dimethylpentylone] 7552 SCHEDULE II (a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it. (b) Narcotic Drugs: Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis: (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol, naloxone, 6β-naltrexol, naltrexone and samidorphan, and their respective salts, but including the following: (i) Raw opium 9600* (ii) Opium extracts 9610* (iii)Opium fluid extracts 9620* Page 15 (iv) Powdered opium 9639* (v) Granulated opium 9640* (vi) Tincture of opium 9630* (vii) Codeine 9050* (viii) Dihydroetorphine 9334* (ix) Ethylmorphine 9190* (x) Etorphine hydrochloride 9059* (xi) Hydrocodone 9193* (xii) Hydromorphone 9150* (xiii) Metopon 9260* (xiv) Morphine 9300* (xv) Oripavine 9330*(9-2007) (xvi) Oxycodone 9143* (xvii) Oxymorphone 9652* (xviii) Thebaine 9333* (xix) Tapentadol 9780-(5-2009) (xx) Noroxymorphone 9668-(4-2021) (2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.* (3) Opium poppy and poppy straw.* (4) Coca leaves (9040) and any salt, compound, derivative, or preparation of coca leaves, (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include: * (i) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine ; * (ii) [123I]ioflupane; or (11-2023) (iii)[18F]FP–CIT (11-2023) (5) Concentrate or poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.* (c) Opiates: (Narcotic Drugs) Unless specifically excepted or unless in another schedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers Page 16 whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designations: (1) Alfentanil 9737-(2-1987) (2) Alphaprodine 9010* (3) Anileridine 9020* (4) Bezitramide 9800* (5) Bulk Dextropropoxyphene (non-dosage forms) 9273-(9-1981) (6) Carfentanil 9743-(9-1988) (7) Dihydrocodeine 9120* (8) Diphenoxylate 9170* (9) Fentanyl 9801* (10) Isomethadone 9226* (11) Levo-alphacetylmethadol (LAAM) 9648-(12-1993) (12) Levomethorphan 9210* (13) Levorphanol 9220* (14) Metazocine 9240* (15) Methadone 9250* (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane 9254* (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane- carboxylic acid 9802* (18) Pethidine (Meperidine) 9230* (19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine 9232* (20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate 9233* (21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid 9234* (22) Phenazocine 9715* (23) Piminodine 9730* (24) Racemethorphan 9732* (25) Racemorphan 9733* (26) Remifentanil 9739-(11-1996) (27) Sufentanil 9740-(9-1981) (28) Thiafentanil 9729-(4-2021) (29) Oliceridine 9245-(5-2022) (30) Tianeptine (5-2022) Page 17 (d) Stimulants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system: (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers 1100* (2) Methamphetamine, its salts, isomers, and salts of its isomers 1105* (3) Lisdexamfetamine 1205*(7-2007) (4) Phenmetrazine and its salts 1631* (5) Methylphenidate 1724* (e) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Amobarbital 2125* (2) Glutethimide 2550-(2-1991) (3) Pentobarbital 2270* (4) Phencyclidine 7471* (5) Secobarbital 2315* (f) Hallucinogenic Substances: (1) Nabilone 7379-(11-1987) [Other name(s) for nabilone: (+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one]. (2) Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration; [(-)-delta-9-trans-tetrahydrocannabinol(delta- 9-THC)]. 7365-(7-2019) (g) Immediate Precursor: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances: (1) Immediate precursor to Amphetamine and Methamphetamine: (i) Phenylacetone 8501-(3-1980) Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl Ketone; methyl benzyl Ketone. (2) Immediate precursor to Phencyclidine (PCP): (i) 1-phenylcyclohexylamine 7460* (ii) 1-piperidinocyclohexanecarbonitrile (PCC) 8603* Page 18 (3) Immediate precursor to Fentanyl: (i) 4-anilino-N-phenethylpiperidine (ANPP) 8333*(8-2010) (ii) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) 8366-(4-2021) SCHEDULE III (a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Stimulants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Section 308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances 1405* (2) Benzphetamine 1228* (3) Chlorphentermine 1645* (4) Clortermine 1647* (5) Phendimetrazine 1615* (c) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system: (1) Any compound, mixture, or preparation containing: (i) Amobarbital 2126* (ii) Secobarbital 2316* (iii)Pentobarbital 2271* (iv) Embutramide 2020*(9-2006) or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. (2) Any suppository dosage form containing: (i) Amobarbital 2126* (ii) Secobarbital 2316* Page 19 (iii)Pentobarbital 2271* or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. (3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof 2100* (4) Chlorhexadol 2510* (5) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act 2012-(2-2001) (6) Ketamine. its salts, isomers, and salts of isomers 7285-(7-1999) Some other names for Ketamine: (+-)-2-(2-Chlorophenyl)-2-(Methylamino)- Cyclohexanone. (7) Lysergic acid 7300* (8) Lysergic acid amide 7310* (9) Methyprylon 2575* (10) Sulfondiethylmethane 2600* (11) Sulfonethylmethane 2605* (12) Sulfonmethane 2610* (13) Tiletamine and zolazepam or any salt thereof 7295-(3-1988) Some trade or other name for a tiletamine- zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)- cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro- 1,3,8-trimethyl-pyrazolo[3,4-e][1,4]diazepin-7(1H)-one; flupyrazapon. (14) Perampanel 2261-(11-2013) (15) Xylazine and any material, compound, mixture, or preparation which contains any quantity of xylazine, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, except in the following uses: (6-2025) (i) Dispensing, prescribing, or administering, to an animal, a drug containing xylazine that has been approved by the United States Secretary of Health and Human Services under section 512 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 360b); (ii) Dispensing, prescribing, or administering xylazine to an animal that is permissible under section 512 (a)(4) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 360b(a)(4)); Page 20 (iii)Possessing a drug containing xylazine, as described in this section (15), for animal use : (A) By a licensed pharmacist or licensed veterinarian ; or (B) Pursuant to a valid prescription from a licensed veterinarian ; (iv) Possessing, manufacturing, distributing, or using xylazine as an active pharmaceutical ingredient for manufacturing an animal drug either: (A) Approved under section 512 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 360b); or (B) Issued an investigation use exemption under section 512 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 360b(j)); (v) Manufacturing, distributing, or using a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or (vi) Another use approved or permissible under the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 301, et seq.) or under 21 CFR Part 530, Subpart B. (d) Nalorphine 9400* (e) Narcotic drugs: Unless specifically excepted or unless listed in another schedule: (1) Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium 9803* (ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9804* (iii)Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts 9807* (iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9808* (v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts 9809* (vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9810* Page 21 (2) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below: (i) Buprenorphine 9064-(6-1985) (10-02 Transfer) (ii) Reserved (f) Anabolic Steroids: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation: 4000 (1) Boldenone; (9-1991) (2) Boldione; (1-2010) (3) Chlorotestosterone (4-chlortestosterone); (9-1991) (4) Clostebol; (9-1991) (5) Dehydrochlormethyltestosterone; (9-1991) (6) Desoxymethyltestosterone (1-2010) (7) Dihydrotestosterone (4-dihydrotestosterone); (9-1991) (8) Drostanolone; (9-1991) (9) Ethylestrenol; (9-1991) (10) Fluoxymesterone; (9-1991) (11) Formebulone (formebolone); (9-1991) (12) Mesterolone; (9-1991) (13) Methandienone, also known as Methandrostenolone; (9-1991) (14) Methandranone; (9-1991) (15) Methandriol; (9-1991) (16) Methenolone; (9-1991) (17) Methyltestosterone; (9-1991) (18) Mibolerone; (9-1991) (19) Nandrolone; (9-1991) (20) 19-Nor-4,9(10)-Androstadienedione (1-2010) (21) Norethandrolone; (9-1991) (22) Oxandrolone; (9-1991) (23) Oxymesterone; (9-1991) (24) Oxymetholone; (9-1991) Page 22 (25) Stanolone; (9-1991) (26) Stanozolol; (9-1991) (27) Testolactone; (9-1991) (28) Testosterone; (9-1991) (29) Trenbolone (9-1991) (30) Prostanozol (8-2012) (31) Methasterone (8-2012); and (32) Any salt, ester, or isomer of a drug or substance described or list in this paragraph, if that salt, ester, or isomer promotes muscle growth. (9-1991) (g) Exempt anabolic steroid products: Compounds, mixtures, or preparations that contain an anabolic steroid that have been exempted by the Secretary: NDC Number (1) Andro-Estro 90-4 0536-1605 (2) Androgyn L.A 0456-1005 (3) Component E-H in Process Pellets Ivy Labs Inc. (4) Component E-H in Process Granulation Ivy Labs Inc (5) Component TE-S in process Granulation Ivy Labs Inc (6) Component TE-S in process Pellets Ivy Labs Inc (7) depANDROGYN 0456-1020 (8) Depo-Testadiol 0009-0253 (9) DEPO-T.E 52765-257 (10) depTESTROGEN 51698-257 (11) Duomone 52047-360 (12) DUO-SPAN II 0684-0102 (13) DURATESTRIN 43797-016 (14) Essian Pharmaceutics (15) Essian H.S Pharmaceutics (16) Esterified Estrogens & Methyltestosterone, USP (0.625 mg/1.25mg) Interpharm (17) Esterified Estrogens & Methyltestosterone, USP (1.25mg/2.5mg) Interpharm (18) Esterified Estrogens & Methyltestosterone (0.625mg/1.25mg) Tablet ANDAPharm (19) Esterified Estrogens & Methyltestosterone (1.25mg/2.5mg) Tablet ANDAPharm (20) Estratest 0032-1026 Page 23 (21) Estratest HS 0032-1023 (22) Menogen 59243-570 (23) Menogen HS 59243-560 (24) Methyltestosterone & Esterified Estrogens (2.5mg/1.25Mg) Lannett Co (25) Methyltestosterone & Esterified Estrogens (Half Strength) (1.25mg/0.625mg) Lannett Co (26) PAN ESTRA TEST 0525-0175 (27) Premarin with Methyltestosterone 0046-0879 (28) Premarin with Methyltestosterone 0046-0878 (29) Syntest D.S 66576-231 (30) Stntest H.S 66576-230 (31) Synovex H in process bulk pellets Syntex Animal (32) Synovex H in process granulation Syntex Animal (33) Synovex Plus in process granulation Fort Dodge (34) Synovex Plus in process bulk pellets Fort Dodge (35) TEST-ESTRO Cypionates 0536-9470 (36) Testoderm with Adhesive 4mg/d Alza Corp (37) Testoderm 4mg/d 17314-4608 (38) Testoderm 6mg/d 17314-4609 (39) Testoderm with Adhesive 6mg/d 17314-2836 (40) Testoderm in process film Alza Corp (41) Testoderm with Adhesive in process film Alza Corp (42) Testosterone Cypionate/Estradiol Cypionate injection 54274-530 (43) Testosterone Cypionate/Estradiol Cypionate injection 0182-3069 (44) Testosterone Cyp 50 Estradiol Cyp 2 0814-7737 (45) Testosterone Cypionate/Estradiol Cypionate injection 0364-6611 (46) Testosterone Cypionate/Estradiol Cypionate injection 0402-0257 (47) Testosterone Enanthate/Estradiol Valerate injection 0182-3073 (48) Testosterone Enanthate/Estradiol Valerate injection 0364-6618 (49) Testosterone Enanthate/Estradiol Valerate injection 0402-0360 (50) Testosterone Ophthalmic Solution Allergan (51) Tilapia Sex Reversal Feed (investigational) Ranger, Inc (h) Veterinary Anabolic Steroid Implant Products: Anabolic steroid products expressly intended for administration through implants in cattle or other nonhuman species exempted by the Secretary. Page 24 NDC/DIN (1) Component E-H 021641-002 (2) Component E-H 01968327 (3) Component TE-S 021641-004 (4) Component T-H 0211641-006 (5) Component T-S 0211641-005 (6) F-TO 00093351 (7) Finaplix-H 12799-807-10 (8) Finaplix-S 12799-807-07 (9) Heifer-old Boehringer (10) Heifer-old Ingelheim (11) Heifer-old Ivy Lab. (12) Implus-H 0009-0434-01 (13) Implus-H 06-0434-01 01968327 (14) Masculinizing Feed for Fish (Invesitigational) Rangen,Inc. (15) Revalor-G 12799-811 (16) Revalor-H 12799-810 (17) Revalor-S 12799-809 (18) Synovex H 0856-3901 (19) Synovex H Syntex (20) Synovex Plus 0856-3904 (21) Tilapia Sex Reversal Feed (investigational) Zeigier Bros. If veterinary products that are granted exempted status are subsequently distributed with the intent that they be used in humans, the distribution would be subject to the criminal sanctions of the CSA despite the drugs’ exempted status. (i) Hallucinogenic substances: (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product 7369-(11-1987) [Some other names for dronabinol: (6a R-trans)-6a,7,8, 10a-tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H-dibenzo [b,d] phyran-1-ol, or (-)-delta 9-(trans)- tetrahydrocannabinol] Page 25 SCHEDULE IV (a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Narcotic drugs: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit 9167* (2) Dextro propoxyphene (alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-methyl-2- propionoxybutane) 9278-(11-1987) (c) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Alprazolam 2882-(6-1982) (2) Barbital 2145* (3) Bromazepam 2748-(1-1985) (4) Camazepam 2749-(1-1985) (5) Chloral betaine 2460* (6) Chloral hydrate 2465* (7) Chlordiazepoxide 2744* (8) Clobazam 2751-(1-1985) (9) Clonazepam 2737* (10) Clorazepate 2768* (11) Clotiazepam 2752-(1-1985) (12) Cloxazolam 2753-(1-1985) (13) Delorazepam 2754-(1-1985) (14) Diazepam 2765* (15) Dichloralphenazone 2467-(10-2002) (16) Estazolam 2756-(1-1985) (17) Ethchlorvynol 2540* (18) Ethinamate 2545* (19) Ethyl loflazepate 2758-(1-1985) Page 26 (20) Fludiazepam 2759-(1-1985) (21) Flunitrazepam 2763-(1-1985) (22) Flurazepam 2767* (23) Fospropofol 2138-(11-2009) (24) Halazepam 2762-(6-1982) (25) Haloxazolam 2771-(1-1985) (26) Ketazolam 2772-(1-1985) (27) Loprazolam 2773-(1-1985) (28) Lorazepam 2885* (29) Lormetazepam 2774-(1-1985) (30) Mebutamate 2800* (31) Medazepam 2836-(1-1985) (32) Meprobamate 2820* (33) Methohexital 2264* (34) Methylphenobarbital (mephorbarbital) 2250* (35) Midazolam 2884-(1-1985) (36) Nimetazepam 2837-(1-1985) (37) Nitrazepam 2834-(1-1985) (38) Nordiazepam 2838-(1-1985) (39) Oxazepam 2835* (40) Oxazolam 2839* (41) Paraldehyde 2585* (42) Petrichloral 2591* (43) Phenobarbital 2285* (44) Pinazepam 2883-(1-1985) (45) Prazepam 2764* (46) Quazepam 2881-(11-1986) (47) Temazepam 2925-(9-1981) (48) Tetrazepam 2886-(1-1985) (49) Triazolam 2887-(7-1983) (50) Zaleplon 2781-(9-1999) (51) Zolpidem 2783-(12-1993) (52) Zopiclone 2784-(1-2006) Page 27 (53) Alfaxalone 2731-(2-2014) (54) Carisoprodol 8192-(4-1997) (55) Tramadol 9752-(8-2007) (56) Suvorexant 2223-(8-2014) (57) Brexanolone 2400-(4-2021) (58) Lemborexant 2245-(4-2021) (59) Remimazolam 2846-(5-2022) (60) Daridorexant 2410-(11-2023) (61) Zuranolone 2420-(6-2025) (d) Stimulants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-Norpseudoephedrine) 1230-(3-1988) (2) Diethylpropion 1610* (3) Fencamfamin 1760-(3-1988) (4) Fenproporex 1575-(3-1988) (5) Lorcaserin 1625-(6-2013) (6) Mazindol 1605-(6-1982) (7) Mefenorex 1580-(3-1988) (8) Modafinil 1680-(1-1999) (9) Pemoline (including organometallic complexes and chelates thereof) 1530* (10) Phentermine 1640* (11) Pipradrol 1750-(9-1981) (12) Serdexmethylphenidate 1729-(11-2023) (13) Sibutramine 1675-(2-1998) (14) Solriamfetol 1650-(4-2021) (15) SPA ((-)-1-dimethylamino-1,2,diphenylethane) 1635-(9-1981) (e) Other substances: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts; isomers whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: Page 28 (1) Pentazocine 9709-(4-1979) (2) Butorphanol 9720-(4-1997) (3) Nalbuphine (4-1997) (4) Eluxadoline 9725-(4-2017) SCHEDULE V (a) Schedule V shall consist of the drugs and other substances by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. (b) Narcotic Drugs: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs and their salts, as set forth below. Reserved (c) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone: (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams. * (2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams. * (3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams. * (4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit. * (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams. * (6) Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit. * (d) Stimulants: unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having stimulant effect on the central nervous system, including its salts, isomers and salts of isomers: (1) Pyrovalerone 1485-(3-1988) (2) Ephedrine:a -{-(Methylamino)ethyl}benzene-methanol; (10-1995) a-{-(methylamino) ethyl}benzyl alcohol; 2-methylamino-1-phenyl-1-propanol; 1-phenyl-1-hydroxy-2-methylaminopropane; 1-phenyl-2-methylaminopropanol; a - hydroxy-b-methylaminopropylbenzene; a product which occurs in the Page 29 Chinese herb Ma Huang (Ephedra vulgaris, Ephedra sinica Stapf., Ephedra equisetina Bunge, Gnetaceae) in several other Ephedra spp. (3) Phenylpropanolamine (7-2005) (4) Pseudoephedrine (7-2005) Pursuant to Ark. Code Ann. § 5-64-212 as amended in 2005, this Schedule V classification shall NOT apply to any ephedrine, phenylpropanolamine, or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form. However, sales limits mandated by statute shall apply to all products with ephedrine, phenylpropanolamine, or pseudoephedrine as a listed ingredient regardless of the dosage form. (e) Depressants: Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid 2782-(1-2006) (2) Lacosamide 2746-(5-2009) (3) Brivaracetam 2710-(4-2017) (4) Lasmiditan 2790-(4-2021) (5) Cenobamate 2720-(4-2021) (6) Ganaxolone 2401-(11-2023) (f) Other substances: (1) None. SCHEDULE VI **** (a) In addition to any substance placed in Schedule VI by the Secretary of the Department of Health under § 5-64-214, any material, compound, mixture, or preparation, whether produced directly or indirectly from a substance of vegetable origin or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, that contains any quantity of the following substances, or that contains any of their salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation, is included in Schedule VI: (1) Marijuana ** (2) Tetrahydrocannabinols, unless the tetrahydrocannabinol is: ** (i) Contained in hemp-derived cannabidiol; (6-2020) (ii) Not more than the lesser of delta-9 tetrahydrocannabinol concentration of more than three tenths of one percent (0.3%) on a dry weight basis for hemp or as otherwise defined by 7 U.S.C. § 1639o, as existing on January 1, 2025, as Page 30 verified by a nationally accredited laboratory for quality, purity and accuracy standards; and (6-2020) ***/**** (iii)Not approved by the United States Food and Drug Administration for marketing as a medication; (6-2020) (3) A synthetic equivalent of: (i) The substance contained in the Cannabis plant; or ** (ii) The substance contained in the resinous extractives of the genus Cannabis; ** (4) Salvia divinorum or Salvinorin A, which includes all parts of the plant presently classified botanically as Salvia divinorum, whether growing or not, the seeds of the plant, any extract from any part of the plant, and every compound, manufacture, derivative, mixture, or preparation of the plant, its seeds, or its extracts, including salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation; ** (5) Synthetic substances, derivatives, or their isomers in the chemical structural classes described below in subdivisions (a)(5)(i)-(a)(5)(x) of this section and also specific unclassified substances in subdivision (a)(5)(xi) of this section. Compounds of the structures described in this subdivision (a)(5), regardless of numerical designation of atomic positions, are included in this subdivision (a)(5). The synthetic substances, derivatives, or their isomers included in this subdivision (a)(5) are: (i) Tetrahydrocannabinols: (A) Tetrahydrocannabinols, including without limitation the following: ** a) Delta-1 cis or trans tetrahydrocannabinol [other name(s): Delta-9 cis or trans tetrahydrocannabinol], and its optical isomers; ** b) Delta-6 cis or trans tetrahydrocannabinol [other name(s): Delta-8 cis or trans tetrahydrocannabinol], and its optical isomers; ** c) Delta- 3,4 cis or trans tetrahydrocannabinol [other name(s): Delta- 6a,10a cis or trans tetrahydrocannabinol], and its optical isomers; ** d) Delta-10 cis or trans tetrahydrocannabinol, and its optical isomers ; *** e) Delta-7 cis or trans tetrahydrocannabinol and its optical isomers; **** f) Ester forms of tetrahydrocannabinol, including: 1) Delta-8 tetrahydrocannabinol acetate ester [other names: Delta-8 tetrahydrocannabinol-O-acetate; Delta-8 tetrahydrocannabinol acetate]; *** 2) Delta-9 tetrahydrocannabinol acetate ester [other names: Delta-9 tetrahydrocannabinol-O-acetate; Delta-9 tetrahydrocannabinol acetate]; *** Page 31 3) Delta-6a,10a tetrahydrocannabinol acetate ester [other name(s): Delta-6a, 10a tetrahydrocannabinol-O-acetate; Delta-6a,10a tetrahydrocannabinol acetate]; *** 4) Delta-10 tetrahydrocannabinol acetate ester [other names: Delta-10 tetrahydrocannabinol-O-acetate; Delta-10 tetrahydrocannabinol acetate]. *** g) Hexahydrocannabinol acetate ester [other name(s) Hexahydrocannabinol-O-acetate; Hexahydrocannabinol acetate]; **** h) Exo-tetrahydrocannabinol; **** i) Metabolites of tetrahydrocannabinol, including 11-hydroxy- tetrahydrocannabinol; **** j) Tetrahydrocannabinolic acid; **** k) Hydrogenated forms of tetrahydrocannabinol, including: Hexahydrocannabinol; **** l) Hexahydrocannabiphorol; **** m) Hexahydrocannabihexol; **** n) Synthetic forms of tetrahydrocannabinol, including dronabinol unless specifically excepted or listed in another schedule, **** o) Ether forms of tetrahydrocannabinol, including: 1) Delta-9 tetrahydrocannabinol methyl ether; and **** 2) Delta-8 tetrahydrocannabinol methyl ether **** p) Ether forms of hexahydrocannabinol; q) Tetrahydrocannabivarins, including Delta-8 tetrahydrocannabivarin but excluding Delta-9 tetrahydrocannabivarin **** r) Delta-8 isotetrahydrocannabinol; **** s) Delta-4(8) isotetrahydrocannabinol; **** t) Iso-hexahydrocannabinol **** u) Analogs of tetrahydrocannabinols with an alkyl chain of four (4) or more carbon atoms, including: 1) Tetrahydrocannabiphorols; **** 2) Tetrahydrocannabioctyls; **** 3) Tetrahydocannabihexols; or **** 4) Tetrahydrocannabutols **** v) Any combination of the compounds listed in this Section (a)(5(i)(A), including: 1) Hexahydrocannabiphorol acetate: **** Page 32 2) Delta-8 tetrahydrocannabiphorol acetate, or **** 3) Delta-9 tetrahydrocannabiphorol acetate; **** w) A product derived from industrial hemp that was produced as a result of a chemical process that converted the industrial hemp or a substance contained in industrial hemp into Delta-8, Delta-9, Delta 6a,10a, or Delta-10 tetrahydrocannabinol including their respective acetate esters and other intoxicating hemp products as defined in Arkansas Code § 20-56-501 et seq.; and ***/**** x) An intoxicating hemp product as defined under Arkansas Code § 20- 56-501, et seq. **** (B) Dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the United States Food and Drug Administration is not a tetrahydrocannabinol under this subdivision (a)(5)(i); ** (ii) Naphthoylindoles, or any compound structurally derived from 3-(1- naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation the following: ** (A) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole; ** (B) JWH-015, or 1-Propyl-2-methyl-3-(1-naphthoyl)indole; ** (C) JWH-018, or 1-Propyl-3-(1-naphthoyl)indole; (D) JWH-019, or 1-Hexyl-3-(1-naphthoyl)indole; ** (E) JWH-073, or 1-Butyl-3-(1-naphthoyl)indole; ** (F) JWH-081, or 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole; ** (G) JWH-098, or 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole; ** (H) JWH-122, or 1-Pentyl-3-(4-methyl-1-naphthoyl)indole; ** (I) JWH-164, or 1-pentyl-3-(7-methoxy-1-naphthoyl)indole; ** (J) JWH-200, or 1-[2-(4-morpholiny)ethyl]-3-(1-naphthoyl) indole; ** (K) JWH-210, or 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole; ** (L) JWH-398, or 1-Pentyl-3-(4-chloro-1-naphthoyl)indole; ** (M) AM-2201, or 1-(5-fluoropentyl)-3-(1-naphthoyl)indole; ** (N) MAM2201, or (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1- naphthalenyl)-methanone; ** (O) EAM2201, or (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)- methanone; and ** Page 33 (P) THJ-2201, or [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone; 7024-(7-2019) (iii)Naphthylmethylindoles, or any compound structurally derived from an H- indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation the following: ** (A) JWH-175, or 1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane; and ** (B) JWH-184, or 1-Pentyl-1H-3-yl-(4-methyl-1-naphthyl)methane; ** (iv) Naphthoylpyrroles, or any compound structurally derived from 3-(1- naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation JWH-307, or (5- (2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone; ** (v) Naphthylmethylindenes, or any compound structurally derived from 1-(1- napthylmethyl)indene with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation JWH-176, or E-1- [1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane; ** (vi) Phenylacetylindoles, or any compound structurally derived from 3- phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including without limitation the following: ** (A) JWH-201, or 2-(4-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone; ** (B) JWH-203, or 1-Pentyl-3-(2-chlorophenylacetyl)indole; ** (C) JWH-250, or 1-Pentyl-3-(2-methoxyphenylacetyl)indole; ** (D) JWH-251, or 1-Pentyl-3-(2-methylphenylacetyl)indole; and ** (E) RCS-8, or 1-(2-cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole; ** (vii) Cyclohexylphenols, or any compound structurally derived from 2-(3- hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted Page 34 in the cyclohexyl ring to any extent, including without limitation the following: ** (A) CP 47,497 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]- phenol; ** (B) Cannabicyclohexanol or CP 47,497 C8 homologue, or 5-(1,1- dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol; and ** (C) CP 55,940, or 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3- hydroxypropyl)cyclohexyl]-phenol; ** (viii) Benzoylindoles, or any compound structurally derived from a 3- (benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including without limitation the following: ** (A) AM-694, or 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole; ** (B) RCS-4, or 1-Pentyl-3-(4-methoxybenzoyl)indole; ** (C) WIN-48,098 or Pravadoline, or (4-Methoxyphenyl)-[2-methyl-1-(2-(4- morpholinyl)ethyl)indol-3-y]methanone; ** (D) AM-2233, or 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole; and ** (E) RCS-4 (C4 homologue) or (4-methoxyphenyl)(1-butyl-1H-indol-3-yl)- methanone; ** (ix) Adamantoylindoles, or Adamantoylindazoles, including Adamantyl Carboxamide Indoles and Adamantyl Carboxamide Indazoles, or any compound structurally derived from 3-(1-adamantoyl) indole, 3-(1- adamantoyl) indazole, or 3-(2-adamantoyl)indole by substitution at a nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole or indazole ring to any extent and whether or not substituted in the adamantly ring to any extent, including without limitation the following: ** (A) AM-1248, or 1-adamantyl-[1-[(1-methylpiperidin-2-yl)methyl]indol-3- yl]methanone; ** (B) AB-001, or 1-adamantyl-(1-pentylindol-3-yl)methanone; ** (C) JWH-018 adamantyl carboxamide, or 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1- yl-1H-indole-3-carboxamide [other name(s): 2NE1, moved in Schedule VI in 2020] ** (D) AKB-48, or N-(1-adamantyl)-pentyl-1H-indazole-3-carboxamide; ** Page 35 (E) 5F-AKB-48, or N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H- indazole-3-carboxamide 7049** (F) STS-135, or N-(1-adamantyl)-1-(5-fluoropentyl)indole-3-carboxamide; ** (x) Tetramethylcyclopropylcarbonylindoles or any compound structurally derived from 3-(2,2,3,3-tetramethylcyclopropylcarbonyl) indole by substitution at the nitrogen atom of the indole ring with alkyl,haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2- yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, including without limitation the following: ** (A) UR-144, or (1-pentylindol-3-yl)-(2,2,3,3- tetramethylcyclopropyl)methanone; ** (B) XLR-11, or [1-(5-fluoropentyl)-1H-indol-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone; ** (C) A-796,260, or [1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone; ** (D) 5-Chloro-UR-144, or ([-(5-chloropentyl)-1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone; ** (E) 5-Bromo-UR-144, or [1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone; and ** (F) A-834,735, or 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone; ** (xi) Unclassified Synthetic Cannabinoids, including without limitation the following: ** (A) CP 50556-1 hydrochloride, or [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3- [(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a- octahydrophenanthridin-1-yl] Acetate; ** (B) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2- methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; ** (C) HU-211, or Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; ** (D) Dimethylheptylpyran or DMHP; ** (E) WIN55,212-2, or 2,3-Dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl-1- naphthalenylmethanone; ** (F) URB597, or [3-(3-carbamoylphenyl)phenyl] N-Cyclohexylcarbamate; ** (G) URB754, or 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one; ** (H) CB-13, or 1-naphthalenyl[4-(pentyloxy)-1 naphthalenyl]-methanone; ** (I) URB602, or cyclohexyl N-(3-phenylphenyl)carbamate; ** Page 36 (J) PB-22, or quinolin-8-yl 1-(5-pentyl)-1H-indole-3-carboxylate; ** (K) 5F-PB-22, or quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; ** (L) BB-22, or quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate; ** (M) NNEI (MN-24), or N-1-naphthalenyl-1-pentyl-1H-indole-3- carboxamide; ** (N) 5F-NNEI, or 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3- carboxamide; ** (O) 5-Fluoro-AMB, or n-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L- valine methyl ester 7033-(9-2018) (P) MMB-CHMICA,or methyl-(1-cyclohexylmethyl)-1H-indole-3-carbonyl)- L-valinate 7044-(9-2018) (Q) 5-Fluoro-ADB, or methyl 2-(1-(5-fluoropentyl)-1H- indazole-3- carboxamido)-3,3-dimethylbutanoate; 7034-(11-2018) (R) 5-Fluoro-MDMB-PICA, or methyl 2-(1-(5-fluoropentyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate 7041-(11-2018) (S) MDMB-CHMICA, or methyl 2-(1-(cyclohexylmethyl)-1H- indole-3- carboxamido)-3,3-dimethylbutanoate; 7042-(11-2018) (T) FUB-AMB, or methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)- 3-methylbutanoate; 7021-(11-2018) (U) MDMB-FUBINACA, or methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate; 7020-(11-2018) (V) AB-PINACA, or N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H- indazole-3-caroboxamide; 7023-(7-2019) (W) AB-CHMINACA, or N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide; 7031-(7-2019) (X) MAB-CHMINACA, or N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide;- (11-2014) (Y) AB-FUBINACA, or N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide;- (9-2018) (Z) ADB-PINACA, or N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide; (9-2018) (AA) 5F-CUMYL-PINACA, or 1-(5-fluoropentyl)-N-(2-phenylpropan-2- yl)-1H-indazole-3-carboxamide 7083-(6-2020) (BB) ADB-FUBINACA, or N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide 7010-(4-2021) (CC) 4-Fluoro-MDMB-BUTINACA, or methyl(S)-2-(1-(4-fluorobutyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate; 7043-(4-2021) Page 37 (DD) 5F-AB-PINACA, or N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide 7025-(5-2022) (EE) 4-CN-CUMYL-BUTINACA, or 1-(4-cyanobutyl)-N-(2-phenylpropan-2- yl)-1H-indazole-3-carboxamide 7089 –(5-2022) (FF) 5F-CUMYL-P7AICA, or 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b]pyridine-3-carboxamide 7085-(5-2022) (GG) NM2201, or Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3- carboxylate 7221-(5-2022) (HH) 5F-EDMB-PINACA, or Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate 7036-(11-2023) (II) FUB-144, or (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone; 7014-(11-2023) (JJ) FUB-AKB48, or N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- carboxamide; 7047-(11-2023) (KK) MDMB-4en-PINACA, or Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H- indazole-3-carboxamido)butanoate; (4-2024) (LL) CH-PIATA, or N-cyclohexyl-2-(1-pentylindol-3-yl)acetamide; (4-2024) (MM) ADB-BUTINACA, or N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- butyl-1H-indazole-3-carboxamide 7027-(6-2025) (6) A synthetic substance, derivative, or its isomers with: (i) Similar chemical structure to any substance described in subdivisions (a)(1)- (a)(5) of this section; or ** (ii) Similar pharmacological effects to any substance described in subdivisions (a)(1)-(a)(5) of this section. ** (b) However, except as provided under subsection (c) of this section, the Secretary shall not delete a controlled substance listed in this section from Schedule VI. (c) A prescription drug approved by the United States Food and Drug Administration under 21 U.S.C. § 355 is excluded from Schedule VI unless the secretary objects under § 5-64-201. *-Scheduled before April, 1979. **-Schedule VI is revised to conform to Act 329 of 2013. *** - Schedule VI is revised further to conform to Act 629 of 2023. Each substance added to the Controlled Substances List pursuant to Act 629 of 2023 shall have the following effective dates: (a) For persons who are under twenty-one (21) years of age, the effective date shall be the effective date of Act 629 of 2023; and, Page 38 (b) For persons who are twenty-one (21) years of age or older, the effective date shall be August 1, 2023. **** Schedule VI is revised further to conform to Act 629 of 2023. Each substance added to the Controlled Substances List pursuant to Act 934 of 2025 shall have the following effective date of August 5, 2025.

Instrument

statute

Source

https://arkleg.state.ar.us/Home/FTPDocument?path=/Assembly/Meeting+Attachments/430/26353/Exhibit+I+-+Controlled+Substance+List.pdf

Retrieved

2026-06-19

Fingerprint

383736ff797cfc9e

**Schedule gap — Schedule I(d) hallucinogens:** "Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substance, or which contains any of its salts, isomers, and salts of isomers … (for purposes of this paragraph only, the term 'isomer' includes the optical, position and geometric isomers)." Named tryptamines: psilocybin, psilocyn, DMT, DET, AMT, bufotenine, 5-MeO-DMT, 5-MeO-DiPT, 5-MeO-DALT — **4-HO-MET not listed.**
— AR State Board of Health Controlled Substances List, Schedule I(d), official (AR legislature-hosted PDF): https://arkleg.state.ar.us/Home/FTPDocument?path=/Assembly/Meeting+Attachments/430/26353/Exhibit+I+-+Controlled+Substance+List.pdf
**Analog act — Ark. Code § 5-64-414:** "'Controlled substance analog' means a substance: (A) The chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or Schedule II or that has a stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to the … effect … of a controlled substance included in Schedule I or Schedule II …" and "(b) A controlled substance analog, to the extent intended for human consumption, is treated for the purposes of this chapter as a substance included in Schedule I."
— Ark. Code § 5-64-414; via labeled Justia mirror: https://law.justia.com/codes/arkansas/title-5/subtitle-6/chapter-64/subchapter-4/section-5-64-414/